The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Computational Scaffold Optimisation for Tissue Engineering. Due to exceptional potential, tissue engineering has attracted over US$4.5 billion research and development investment and another US$2.6 billion market capital since 1990. It is important to cement Australia's position in such a highly competitive field. This project aims to develop a novel technology for scaffold-based tissue engineering, which would help Australia lead in the relevant area and increase its competitiveness in the futu ....Computational Scaffold Optimisation for Tissue Engineering. Due to exceptional potential, tissue engineering has attracted over US$4.5 billion research and development investment and another US$2.6 billion market capital since 1990. It is important to cement Australia's position in such a highly competitive field. This project aims to develop a novel technology for scaffold-based tissue engineering, which would help Australia lead in the relevant area and increase its competitiveness in the future global market of biomaterials, tissue products, biomedical software and instruments. An enormous socio-economic benefit to Australia would be a significant improvement in the clinical success rate for our ageing population. Read moreRead less
Graded Biomaterial for Articular Cartilage Replacement. Osteoarthritis is a major health and economical burden on the Australian community which can be addressed in part by providing a viable option for effective clinical treatment. 34% of people over the age of 50 suffer from osteoarthritis, predominantly the knee. The development of a biomaterial to enable repair of articular cartilage through minor surgical procedures will release resources at point of care. Current biomaterial options are st ....Graded Biomaterial for Articular Cartilage Replacement. Osteoarthritis is a major health and economical burden on the Australian community which can be addressed in part by providing a viable option for effective clinical treatment. 34% of people over the age of 50 suffer from osteoarthritis, predominantly the knee. The development of a biomaterial to enable repair of articular cartilage through minor surgical procedures will release resources at point of care. Current biomaterial options are still in infancy and an Australian based product would benefit the Australian economy as well as Australia's international standing within the biomaterials community.Read moreRead less
NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and ....NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and then polymerising the micelles in a biodegradable polymer scaffold. This would enable local delivery of osteogenic growth factors to a bone defect.Read moreRead less
Stem cell-based interface tissue engineering. Osteoarthritis (OA) causes extreme pain, disability, and reduced quality of life and overall productivity. It is the musculoskeletal disorder with the greatest social and economic implications internationally, with 9.3% of the adult population projected to suffer from OA by 2030. A tissue engineered product capable of functional repair of ligament-cartilage-bone tissue interfaces will have significant benefits. It will improve patient activity and qu ....Stem cell-based interface tissue engineering. Osteoarthritis (OA) causes extreme pain, disability, and reduced quality of life and overall productivity. It is the musculoskeletal disorder with the greatest social and economic implications internationally, with 9.3% of the adult population projected to suffer from OA by 2030. A tissue engineered product capable of functional repair of ligament-cartilage-bone tissue interfaces will have significant benefits. It will improve patient activity and quality of life, and significantly reduce OA-associated health care costs. This proposal will train a total of 12 new generation researchers in the emergent fields of stem cell biology and tissue engineering, having important benefits for the Australian scientific and industrial communities.Read moreRead less